DR. MARTENS PLC financials
DR. MARTENS PLC
Country: GB Reporting currency: GBP Latest annual report: 2026-03-29
LEI:
213800QPT8YM6NQZPH28 ISIN: GB00BL6NGV24 Financial statements
(GBP, as reported — unscaled; 96 line items across 2 annual periods)
| Line item | 2026 | 2025 |
|---|---|---|
| Income statement | ||
| Revenue | £764.9M | £787.6M |
| Cost of sales | £258.9M | £275.9M |
| Gross profit | £506.0M | £511.7M |
| Net finance income / (cost) | -£24.3M | -£28.2M |
| Finance costs | £28.0M | £32.0M |
| Profit before tax | £32.7M | £8.8M |
| Income tax expense | £8.9M | £4.3M |
| Profit for the year | £23.8M | £4.5M |
| Total comprehensive income | £21.1M | £500.0K |
| Per share | ||
| Basic EPS | £0.03 | £0.01 |
| Diluted EPS | £0.02 | £0.01 |
| Free cash flow / share | £0.13 | £0.21 |
| Cash flow statement | ||
| Cash generated from operations | £154.9M | £204.7M |
| Net cash from operating activities | £142.7M | £196.3M |
| Net cash from investing activities | -£8.2M | -£15.3M |
| Purchase of PP&E (capex) | £9.2M | £8.4M |
| Purchase of intangibles | £2.7M | £10.3M |
| Net cash from financing activities | -£107.8M | -£134.2M |
| Dividends paid | £24.6M | £9.5M |
| Proceeds from borrowings | £0 | £250.0M |
| Repayments of borrowings | £0 | £283.0M |
| Lease liability payments | £49.3M | £49.3M |
| Net change in cash | £26.7M | £46.8M |
| Balance sheet | ||
| Total assets | £877.3M | £889.8M |
| Non-current assets | £460.2M | £478.9M |
| Property, plant & equipment | £43.5M | £49.6M |
| Right-of-use assets | £131.3M | £143.2M |
| Intangible assets & goodwill | £270.4M | £274.0M |
| Current assets | £417.1M | £410.9M |
| Inventories | £160.8M | £187.4M |
| Trade & other receivables | £70.7M | £62.4M |
| Cash & equivalents | £180.3M | £155.9M |
| Total equity | £361.5M | £366.4M |
| Non-current liabilities | £355.9M | £364.8M |
| Long-term borrowings | £247.6M | £246.3M |
| Lease liabilities (non-current) | £99.7M | £109.5M |
| Current liabilities | £159.9M | £158.6M |
| Short-term borrowings | £2.1M | £2.4M |
| Lease liabilities (current) | £44.1M | £45.9M |
| Trade & other payables | £112.3M | £108.9M |
| Deferred tax liabilities | £1.3M | £2.5M |
| Derived metrics | ||
| Free cash flow | £133.5M | £187.9M |
| Net margin | 3.1% | 0.6% |
| Return on equity | 6.6% | 1.2% |
| Cash conversion ratio | 6.00× | 43.62× |
| Capex coverage | 15.51× | 23.37× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | £23.5M | £62.7M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -£8.8M | £6.3M |
| Adjustments For Depreciation and Amortisation Expense | £72.6M | £76.8M |
| Adjustments For Finance Costs | £28.0M | £32.0M |
| Adjustments For Finance Income | £3.7M | £3.8M |
| Adjustments For Income Tax Expense | £8.9M | £4.3M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | £600.0K | £0 |
| Adjustments For Increase Decrease In Trade and Other Payables | £5.1M | £15.3M |
| Adjustments For Sharebased Payments | £5.2M | £7.2M |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -£900.0K | £3.1M |
| Capital Redemption Reserve | £400.0K | £400.0K |
| Current Derivative Financial Assets | £500.0K | £1.0M |
| Current Derivative Financial Liabilities | £200.0K | £100.0K |
| Current Tax Assets | £4.8M | £4.2M |
| Current Tax Liabilities | £1.2M | £1.3M |
| Deferred Tax Assets | £11.0M | £11.1M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | £0 | £0 |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | £16300000.00 | £16400000.00 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -£2.3M | -£2.0M |
| Finance Income | £3.7M | £3.8M |
| Income Tax Relating To Cash Flow Hedges of Other Comprehensive Income | -£100.0K | -£300.0K |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | £900.0K | £0 |
| Income Taxes Paid Refund Classified As Operating Activities | £10.9M | £12.2M |
| Increase Decrease In Working Capital | -£19.8M | -£84.3M |
| Increase Decrease Through Sharebased Payment Transactions | £5.2M | £7.2M |
| Interest Paid Classified As Financing Activities | £20.9M | £31.5M |
| Interest Received Classified As Investing Activities | £3.7M | £3.4M |
| Investments Other Than Investments Accounted For Using Equity Method | £1.0M | £1.0M |
| Issue of Equity | £100.0K | £0 |
| Issued Capital | £9.7M | £9.6M |
| Liabilities | £515.8M | £523.4M |
| Merger Reserve | -£1.40B | -£1.40B |
| Net Assets Liabilities | £361.5M | £366.4M |
| Noncurrent Derivative Financial Assets | £0 | £0 |
| Noncurrent Provisions | £7.3M | £6.5M |
| Noncurrent Recognised Assets Defined Benefit Plan | £3.0M | £0 |
| Other Adjustments To Reconcile Profit Loss | -£700.0K | £100.0K |
| Other Comprehensive Income | -£2.7M | -£4.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -£1.9M | -£300.0K |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -£5.2M | -£3.1M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | £3.6M | £0 |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -£2.7M | -£4.0M |
| Payments To Acquire Or Redeem Entitys Shares | £6.7M | £0 |
| Purchase of Treasury Shares | £6.7M | — |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | -£1.3M | £200.0K |
| Reserve of Exchange Differences On Translation | £1.4M | £6.6M |
| Reserve of Gains and Losses On Hedging Instruments That Hedge Investments In Equity Instruments | £200.0K | £700.0K |
| Retained Earnings | £1.76B | £1.75B |
| Selling General and Administrative Expense | £449.0M | £474.7M |
| Treasury Shares | £6.7M | £0 |
Methodology
Every line item above is a fact tagged in DR. MARTENS PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (GBP), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.